Table 4.
Prognostic factors for DFS and OS in patients with HBV-related HCC by multivariate COX regression analyses
| Variables | DFS | OS | ||
|---|---|---|---|---|
|
|
|
|||
| HR (95% CI) | P | HR (95% CI) | P | |
| Tumor diameter | 1.599 (1.180-2.167) | 0.002 | ||
| Tumor number | 1.922 (1.430-2.584) | < 0.001 | ||
| Pathological differentiation | 1.705 (1.114-2.608) | 0.014 | ||
| GPR | 1.900 (1.402-2.574) | < 0.001 | 2.375 (1.287-4.386) | 0.006 |
| Fibrinogen | 1.921 (1.280-2.885) | 0.002 | 2.395 (1.248-4.599) | 0.009 |
| AFP | 2.353 (1.321-4.193) | 0.004 | ||
| HBV-DNA | 2.286 (1.254-4.165) | 0.007 | ||
AFP: alpha fetoprotein, HBV: hepatitis B virus, GPR: gamma-glutamyl transpeptidase to platelet ratio, DFS: disease-free survival, OS: overall survival, HR: hazard ratio, CI: confidence interval.